CD274 and neoplasm: From there on, a continuous encounter with persistent tumor antigens (rather than microenvironmental factors such as PDL-1 upregulation) drives T-cell dysfunction, possibly explaining the incongruent results regarding PDL-1 expression in tumors and response to anti-PD-1 therapy [47].